Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients

Joong Bae Ahn; Sun Young Rha; Sang Joon Shin; Hei Cheul Jeung; Tae Soo Kim; Xianglan Zhang; Kyu Hyun Park; Sung Hoon Noh; Jae Kyung Roh; Hyun Cheol Chung

doi:10.1016/j.canlet.2009.06.031

Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients

Joong Bae Ahn, Sun Young Rha, Sang Joon Shin, Hei Cheul Jeung, Tae Soo Kim, Xianglan Zhang, Kyu Hyun Park, Sung Hoon Noh, Jae Kyung Roh, Hyun Cheol Chung

Department of Internal Medicine

Research output: Contribution to journal › Article › peer-review

32 Citations (Scopus)

Abstract

It has been suggested that vasculogenesis by endothelial progenitor cells (EPC) as well as angiogenesis play an important role in the production of blood vessels in neoplasm. The present study was designed to isolate and characterize the EPC in gastric cancer patients as a tumor specific angiogenesis marker. The cells derived from CD34 positive PBMC presented with a cobblestone appearance at 28 days, revealing differentiation into endothelial cells. They were also positive to the LDL-uptake reaction, showing that they have biological endothelial cell functions. These cells demonstrated tube formation, showing their ability to participate in neovascularization. The cells derived from CD34 positive PBMC expressed CD133 and demonstrated telomerase activity, showing the stem cell character. In xenograft model, EPC derived from CD34 positive PBMC mobilized mainly into tumor area after being injected through tail vein. With isolation, ex vivo amplification and characterization of EPC from gastric cancer patients receiving chemotherapy, endothelial progenitor cells may be used as a candidate prognostic and predictive biomarker for cancer.

Original language	English
Pages (from-to)	124-132
Number of pages	9
Journal	Cancer Letters
Volume	288
Issue number	1
DOIs	https://doi.org/10.1016/j.canlet.2009.06.031
Publication status	Published - 2010 Feb 1

Bibliographical note

Funding Information:
This work was supported by the Korea Science and Engineering Foundation (KOSEF) through the Cancer Metastasis Research Center (CMRC) at Yonsei University College of Medicine.

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.canlet.2009.06.031

Cite this

@article{e7c1dc5a25034fc7ad86d45e680f0952,

title = "Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients",

abstract = "It has been suggested that vasculogenesis by endothelial progenitor cells (EPC) as well as angiogenesis play an important role in the production of blood vessels in neoplasm. The present study was designed to isolate and characterize the EPC in gastric cancer patients as a tumor specific angiogenesis marker. The cells derived from CD34 positive PBMC presented with a cobblestone appearance at 28 days, revealing differentiation into endothelial cells. They were also positive to the LDL-uptake reaction, showing that they have biological endothelial cell functions. These cells demonstrated tube formation, showing their ability to participate in neovascularization. The cells derived from CD34 positive PBMC expressed CD133 and demonstrated telomerase activity, showing the stem cell character. In xenograft model, EPC derived from CD34 positive PBMC mobilized mainly into tumor area after being injected through tail vein. With isolation, ex vivo amplification and characterization of EPC from gastric cancer patients receiving chemotherapy, endothelial progenitor cells may be used as a candidate prognostic and predictive biomarker for cancer.",

author = "Ahn, {Joong Bae} and Rha, {Sun Young} and Shin, {Sang Joon} and Jeung, {Hei Cheul} and Kim, {Tae Soo} and Xianglan Zhang and Park, {Kyu Hyun} and Noh, {Sung Hoon} and Roh, {Jae Kyung} and Chung, {Hyun Cheol}",

note = "Funding Information: This work was supported by the Korea Science and Engineering Foundation (KOSEF) through the Cancer Metastasis Research Center (CMRC) at Yonsei University College of Medicine.",

year = "2010",

month = feb,

day = "1",

doi = "10.1016/j.canlet.2009.06.031",

language = "English",

volume = "288",

pages = "124--132",

journal = "Cancer Letters",

issn = "0304-3835",

publisher = "Elsevier Ireland Ltd",

number = "1",

}

TY - JOUR

T1 - Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients

AU - Ahn, Joong Bae

AU - Rha, Sun Young

AU - Shin, Sang Joon

AU - Jeung, Hei Cheul

AU - Kim, Tae Soo

AU - Zhang, Xianglan

AU - Park, Kyu Hyun

AU - Noh, Sung Hoon

AU - Roh, Jae Kyung

AU - Chung, Hyun Cheol

N1 - Funding Information: This work was supported by the Korea Science and Engineering Foundation (KOSEF) through the Cancer Metastasis Research Center (CMRC) at Yonsei University College of Medicine.

PY - 2010/2/1

Y1 - 2010/2/1

N2 - It has been suggested that vasculogenesis by endothelial progenitor cells (EPC) as well as angiogenesis play an important role in the production of blood vessels in neoplasm. The present study was designed to isolate and characterize the EPC in gastric cancer patients as a tumor specific angiogenesis marker. The cells derived from CD34 positive PBMC presented with a cobblestone appearance at 28 days, revealing differentiation into endothelial cells. They were also positive to the LDL-uptake reaction, showing that they have biological endothelial cell functions. These cells demonstrated tube formation, showing their ability to participate in neovascularization. The cells derived from CD34 positive PBMC expressed CD133 and demonstrated telomerase activity, showing the stem cell character. In xenograft model, EPC derived from CD34 positive PBMC mobilized mainly into tumor area after being injected through tail vein. With isolation, ex vivo amplification and characterization of EPC from gastric cancer patients receiving chemotherapy, endothelial progenitor cells may be used as a candidate prognostic and predictive biomarker for cancer.

AB - It has been suggested that vasculogenesis by endothelial progenitor cells (EPC) as well as angiogenesis play an important role in the production of blood vessels in neoplasm. The present study was designed to isolate and characterize the EPC in gastric cancer patients as a tumor specific angiogenesis marker. The cells derived from CD34 positive PBMC presented with a cobblestone appearance at 28 days, revealing differentiation into endothelial cells. They were also positive to the LDL-uptake reaction, showing that they have biological endothelial cell functions. These cells demonstrated tube formation, showing their ability to participate in neovascularization. The cells derived from CD34 positive PBMC expressed CD133 and demonstrated telomerase activity, showing the stem cell character. In xenograft model, EPC derived from CD34 positive PBMC mobilized mainly into tumor area after being injected through tail vein. With isolation, ex vivo amplification and characterization of EPC from gastric cancer patients receiving chemotherapy, endothelial progenitor cells may be used as a candidate prognostic and predictive biomarker for cancer.

UR - http://www.scopus.com/inward/record.url?scp=73649122842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73649122842&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2009.06.031

DO - 10.1016/j.canlet.2009.06.031

M3 - Article

C2 - 19619937

AN - SCOPUS:73649122842

SN - 0304-3835

VL - 288

SP - 124

EP - 132

JO - Cancer Letters

JF - Cancer Letters

IS - 1

ER -

Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this